Purpose Chemotherapy-induced peripheral neuropathy is an unpleasant symptom
experienced by most cancer survivors who receive neurotoxic chemotherapy. It is not life …

Clinicians should be aware of the potential for persistent TIPN and its impact on patients'
function and QOL. Future research should focus on large prospective studies with systematic …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and
dose-limiting side effect of systemic cancer therapy. In many cancer survivors, CIPN persists …

Chemotherapy-provoked peripheral neuropathy and its linked comorbidities severely
reduce the quality of a patient's life. Its therapy is not completely resolved and has become …

Persistent taxane-induced peripheral neuropathy (TIPN) is highly prevalent among early-
stage breast cancer survivors (ESBCS) and has detrimental effect on quality of life. We …

Purpose Clinical practice guidelines recommend altering neurotoxic chemotherapy
treatment in patients experiencing intolerable chemotherapy-induced peripheral neuropathy …

Simple Summary Chemotherapy-induced peripheral neuropathy is highly relevant in breast
cancer because of the symptoms it triggers and its corresponding negative impact on health …

Chemotherapy-provoked peripheral neuropathy and its associated affective disorders are
important adverse effects in cancer patients, and its treatment is not completely resolved. A …

Background Chemotherapy is one of the most widely used therapies for breast cancer,
triggering important repercussions on people's quality of life. However, little research has …

Background: Chemotherapy has relevant implications for cancer patients' physical, social,
and psychological health. Foot health has gained relevance in recent years due to its …